Literature DB >> 9514783

Determination of transport parameters of permeant substrates of the vesicular amine transporter.

V G Romanenko1, R Gebara, K M Miller, D Njus.   

Abstract

Biological transport of moderately permeant compounds is obscured by diffusion of the compounds back across the membrane, so characterization of the transport of such compounds requires correction for permeability. A relatively simple method for determining kinetic parameters for moderately permeant compounds is presented here. After evaluating a compound's apparent permeability coefficient, its steady-state uptake is measured as a function of concentration. By comparing the concentration dependence of uptake measured both in the presence and in the absence of a complete inhibitor of the transporter, K(m) and Vmax for transport of that substrate may be calculated. When used to analyze transport of tyramine and hydroxyephedrine by the vesicular amine transporter, this method yields results consistent with other methods and with values for analogous impermeant substrates. In bovine adrenal chromaffin vesicles, tyramine and (-)erythro-hydroxyephedrine have apparent permeability coefficients of 4.7 +/- 1.0 x 10(-9) and 1.1 +/- 0.4 x 10(-8) cm/s, respectively. Values for K(m) are 15 +/- 9 and 34 +/- 14 microM and for Vmax are 1.3 +/- 0.2 and 1.4 +/- 0.9 nmol/min.mg of membrane protein, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514783     DOI: 10.1006/abio.1997.2546

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.

Authors:  I Hussain; G W Bate; J Henry; P Djali; R Dimaline; G J Dockray; A Varro
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

2.  Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.

Authors:  Kristal R Tucker; Ethan R Block; Edwin S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.